44.17000 EUR
0.26
0.59%
Last update Dec 17, 7:31 PM CET
Main market
Day range
44.049999
44.43000
Previous close
43.91000
Open
44.060001
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
44.17
0.26
0.59%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 2.4B 2.4B 2.1B 1.8B
Cost of revenue 494.6M 532.1M 503.0M 470.5M
Gross profit 1.9B 1.9B 1.6B 1.4B
Operating expense
Research & development 637.0M 746.8M 649.6M 628.8M
Selling general and admin 860.2M 892.4M 823.2M 759.4M
Other operating expenses
Operating income 404.2M 185.8M 57.4M -74.3M
Non operating interest income
Income 63.8M 58.3M 18.0M 10.5M
Expense 10.5M 13.8M 13.8M 14.7M
Other income expense 4.5M -38.2M 90.1M 3.8M
Pretax income 461.8M 188.6M 149.6M -75.4M
Tax provision 98.0M 20.9M 8.0M -11.3M
Net income 363.9M 167.6M 141.6M -64.1M
Basic EPS 2.3 0.9 0.8 -0.4
Diluted EPS 2.2 0.9 0.8 -0.4
Basic average shares 162.0M 195.5M 192.8M 190.3M
Diluted average shares 162.0M 195.5M 192.8M 190.3M
EBITDA 546.0M 306.8M 161.8M 55.4M
Net income from continuing op. 363.9M 167.6M 141.6M -64.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 44 minutes

19:15
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).